1. Editor's page

   EditorialNotes Pages: 189 - 189

2. Genetic alterations in primary breast cancer

   • Robert Callahan

   11th San Antonio Breast Cancer Symposium-Plenary Lecture Pages: 191 - 203

3. Exposure, susceptibility, and breast cancer risk: A hypothesis regarding exogenous carcinogens, breast tissue development, and social gradients, including black/white differences, in breast cancer incidence

   • Nancy Krieger

   OriginalPaper Pages: 205 - 223

4. Treatment of stage III breast cancer

   • William L. McGuire
   • Martin D. Abeloff
   • Sandra M. Swain

   Viewpoints Pages: 225 - 235

5. Influence of radiotherapy on the dose of adjuvant chemotherapy in early breast cancer

   • F. Habibollahi
   • I. S. Fentiman
   • R. D. Rubens

   Report Pages: 237 - 241

6. Phytohaemagglutinin responsiveness of peripheral lymphocytes and survival in patients with primary breast cancer

   • Aileen Burford-Mason
   • Gillian M. L. Gyte
   • Sylvia M. Watkins

   Report Pages: 243 - 250

7. Beta-adrenergic receptors in DMBA-induced rat mammary tumors: Correlation with progesterone receptor and tumor growth

   • Bianca Marchetti
   • Paulo G. Spinola
   • Fernand Labrie

   Report Pages: 251 - 263

8. Progestin inhibition of estrogen-dependent proliferation in ZR-75-1 human breast cancer cells: Antagonism by insulin

   • Richard Poulin
   • Jean -Marc Dufour
   • Fernand Labrie

   Report Pages: 265 - 276

9. Hereditary breast cancer and possible risk of mammography

   • F. J. H. Sluijter
   • J. W. Koten
   • W. Den Otter

   Correspondence Pages: 277 - 277

10. Menstrual history and breast cancer surgery

    • Scott A. Gruber
    • Kristin L. Nichol
    • William J. M. Hrushesky

    Correspondence Pages: 278 - 278

11. Proliferative index of breast carcinoma by thymidine labeling: prognostic power independent of stage, estrogen and progesterone receptors

    • J S Meyer

    Erratum Pages: 279 - 279

12. Announcement

    Announcement Pages: 285 - 286